Boston Scientific (BSX)
(Delayed Data from NYSE)
$105.41 USD
+0.49 (0.47%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $105.40 -0.01 (-0.01%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth C Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, Boston Scientific Corporation has a PEG ratio of 2.66 compared to the Medical - Products industry's PEG ratio of 2.14.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
BSX 105.41 +0.49(0.47%)
Will BSX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BSX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BSX
OPK Stock Slips Following Q2 Earnings Miss, Gross Margin Expands
TMDX Stock Gains Post Q2 Earnings & Revenue Beat, Margins Up
BSX: What are Zacks experts saying now?
Zacks Private Portfolio Services
GEHC vs. BSX: Which Stock Is the Better Value Option?
Is It Worth Investing in Boston Scientific (BSX) Based on Wall Street's Bullish Views?
Resmed Q4 Earnings & Revenues Beat Estimates, Stock Up, Margins Climb
Other News for BSX
Beyond the Balance Sheet: What SWOT Reveals About Boston Scientific Corp (BSX)
1 ETF That Has Beaten The S&P Since Inception And 1 New ETF That Yields Over 12%
See Which Of The Latest 13F Filers Holds BSX
Insider Sell: Yoshiaki Fujimori Sells Shares of Boston Scientific Corp (BSX)
What's Driving the Market Sentiment Around Boston Scientific?